Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

362.90p
   
  • Change Today:
      2.90p
  • 52 Week High: 415.20p
  • 52 Week Low: 348.10p
  • Currency: UK Pounds
  • Shares Issued: 8,957m
  • Volume: 15,334,714
  • Market Cap: £32,506m

Pfizer exits Haleon with £2.4bn stake sale

By Benjamin Chiou

Date: Wednesday 19 Mar 2025

LONDON (ShareCast) - (Sharecast News) - Pfizer has fully exited its investment in UK-listed pharma group Haleon, selling off its remaining 7.3% stake for £2.5bn.
The transaction marks an "important milestone" for Haleon, according to chief executive Brian McNamara, with Pfizer having held a 32% stake at the time of the company's spin-off from GSK in July 2022.

"Nearly three years on from demerger, Haleon is in a position of strength and is well placed to capitalise on the significant opportunities ahead," he said.

Haleon was originally formed in 2019 from the merger of GSK and Pfizer's consumer healthcare divisions - GSK owned two thirds, while Pfizer owned the rest - before being spun off by GSK three years later.

As part of Wednesday's deal, Pfizer sold around 618m shares in Haleon to institutional investors at a price of 385p - a slight discount to Tuesday's closing price of 391.1p - while Haleon made an off-market purchase of 44m shares from Pfizer at the same price for £170m.

The off-market purchase is part of the £500m allocated to share buybacks in 2025, which Haleon announced last month.

"Our participation in the offering is consistent with our disciplined capital allocation priorities, and supports our commitment to deliver attractive returns for shareholders, underpinned by a strong investment grade balance sheet," McNamara said.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Haleon Market Data

Currency UK Pounds
Share Price 362.90p
Change Today 2.90p
% Change 0.81 %
52 Week High 415.20p
52 Week Low 348.10p
Volume 15,334,714
Shares Issued 8,957m
Market Cap £32,506m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average
51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average
Price Trend
3.14% below the market average3.14% below the market average3.14% below the market average3.14% below the market average3.14% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Income
10.34% below the market average10.34% below the market average10.34% below the market average10.34% below the market average10.34% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
9.51% below the market average9.51% below the market average9.51% below the market average9.51% below the market average9.51% below the market average
72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average

Haleon Dividends

  Latest Previous
  Interim Final
Ex-Div 14-Aug-25 24-Apr-25
Paid 18-Sep-25 05-Jun-25
Amount 2.20p 4.60p

Trades for 29-Aug-2025

Time Volume / Share Price
16:47 90,761 @ 363.17p
16:35 2,446 @ 362.90p
16:35 116,021 @ 362.90p
16:35 3,765 @ 362.90p
16:35 23,805 @ 362.90p

Haleon Key Personnel

CEO Brian McNamara
CFO Dawn Allen

Top of Page